Response to long-term growth hormone therapy in short children with reduced GH bioactivity

Hormone Research

Volumn 66, Issue 4, 2006, Pages 189-194

  Travaglino, Paola ^a   Buzi, Fabio ^b   Meazza, Cristina ^a   Pagani, Sara ^a   Tinelli, Carmine ^c   Iughetti, Lorenzo ^d   De Sanctis, Vincenzo ^e   Aimaretti, Gianluca ^f   Poddighe, Dimitri ^a   Barberi, Salvatore ^a   Bozzola, Mauro ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

Author keywords

Growth hormone bioinactivity; Growth hormone deficiency; Growth hormone treatment; Growth velocity; Nb2 cell bioassay

Indexed keywords

GROWTH HORMONE;

ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFECT; DRUG RESPONSE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HORMONAL THERAPY; HUMAN; MALE; PRIORITY JOURNAL;

BODY HEIGHT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DWARFISM, PITUITARY; FEMALE; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; MALE; PUBERTY; TIME;

EID: 33748796632     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094483     Document Type: Article

References (24)

1. GH Research Society: Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary Statement of the GH Research Society. J Clin Endocrinol Metab 2000;85:3990-3993.
2. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB: Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993;76:1610-1616.
3. Kowarski AA, Schneider J, Ben-Galim E, Welden VV, Daughady WH: Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH. J Clin Endocrinol Metab 1978;47:461-464.
4. Lewis MD, Horan M, Millar DS, Newsway V, Easter TE, Fryklund L, Gregory JW, Norin M, Del Valle C-J, Lpez-Siguero JP, Canete R, Lopez-Canti LF, Diaz-Torrado N, Espino R, Ulied A, Scanlon MF, Procter AM, Cooper DN: A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway. J Clin Endocrinol Metab 2004;89:1068-1075.
5. Takahashi Y, Kaji H, Okimura Y, Goji K, Abe H, Chihara K: Short stature caused by a mutant growth hormone with an antagonist effect. Endocr J 1996;43;(suppl):S27-S32.
6. Tanaka T, Shiu RP, Gout PW, Beer CT, Noble RL, Friesen HG: A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab 1980;51:1058-1063.
7. Bozzola M, Radetti G, Buzi F, Tonini G, Moretta A, Autelli M, Aglialoro A, Rondini G, Barreca A: Growth hormone bioactivity and immunoactivity in tall children. J Endocrinol Invest 1999;22:541-546.
8. 2 cell bioassay in children with growth disorders. J Endocrinol Invest 1998;21:765-770.
9. Tanner JM, Whitehouse RH: Clinical longitudinal standards for height, weight, height velocity, and stages of puberty. Arch Dis Child 1976;51:170-179.
10. Schwarze CP, Wollmann HA, Binder G, Ranke MB: Short-term increments of insulin-like growth factor I (IGF-I) and IGF-binding pretein-3 predict the growth response to growth hormone (GH) therapy in GH-sensitive children. Acta Paediatr Suppl 1999;88:200-208.
11. Cotterill AM, Camacho-Ubner C, Dunquesnoy P, Savage MO: Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature. Clin Endocrinol 1998;48:719-724.
12. 2 node lymphoma cells. Endocrinology 1987;120:2389-2397.
13. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall, Skakkebaek NS: Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 1994;78:744-752.
14. Juul A, Dalgaard P, Blum WF, Bang P, Hall K, Michaelsen KF, Muller J, Skakkebaek NS: Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 1995;80:2534-2542.
15. Laron Z, Pertzelan A, Mannheimer S: Genetic pituitary dwarfism with high serum concentration of growth hormone - a new inborn error of metabolism. Isr J Med Sci 1966;2:152-155.
16. Rosenfeld RG, Kofoed E, Little B, Woods K, Bickway C, Pratt K, Hwa V: Growth hormone insensitivity resulting from post-GH receptor defects. Growth Horm IGF Res 2004;14:S35-S38.
17. Chen X, Song F, Dai Y, Bao X, Jin Y: A novel mutation of growth hormone receptor gene (GHR) in a Chinese girl with Laron Syndrome. J Pediatr Endocrinol Metab 2003;16:1183-1189.
18. Dattani MT, Hindmarsh PC, Pringle PJ, Brook CGD, Marshall NJ: The measurement of growth hormone bioactivity in patient serum using an eluted stain assay. J Clin Endocrinol Metab 1995;80:2675-2683.
19. Strasburger CJ, Wu Z, Pflaum CD, Dressendorfer RA: Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement. J Clin Endocrinol Metab 1996;81:2613-2620.
20. Binder G, Benz MR, Elmlinger M, Pflaum C-D, Strasburger CJ, Ranke MB: Reduced human growth hormone(hGH) bioactivity without a defect of the GH-1 gene in three patients with rhGH responsive growth failure. Clin Endocrinol 1999;51:89-95.
21. Besson A, Salemi S, Deladoey J, Vuissoz J-M, Eblé A, Bidlingmaier M, Burgi S, Honegger U, Fluck C, Mullis PE: Short stature caused by a biologically inactive mutant growth hormone (GH-C53S). J Clin Endocrinol Metab 2005;90:2493-2499.
22. Tanaka T, Shishiba Y, Gout PW, Beer CT, Noble RL, Friesen HG: Radioimmunoassay and bioassay of human growth hormone and human prolactin. J Clin Endocrinol Metab 1983;56:18-20.
23. Frasier SD: Human pituitary growth hormone (hGH) therapy in growth hormone deficiency. Endocr Rev 1983;4:155-170.
24. Rudman D, Kutner MH, Blackston D, Cushman RA, Bain RP, Patterson JH: Children with normal-variant short stature: treatment with human growth hormone for six months. N Engl J Med 1981;305:123-131.